Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LTG-001 for acute postoperative pain following extraction of impacted third molars has completed, assessing efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LTG-001 (LTG-001)

Snippet

Sponsor: Latigo Biotherapeutics | Conditions: Acute Pain, Postoperative | Phase 2 | Status: COMPLETED